Adamas Pharmaceuticals Provides Review of 2015 and Projected Future Milestones
Jan 12, 2016 21:05 pm UTC| Business
EMERYVILLE, Calif., Jan. 12, 2016 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today is providing a summary of 2015 corporate highlights and planned future milestones. Adamas, which is developing new...
Jan 12, 2016 21:05 pm UTC| Business
NEW YORK, Jan. 12, 2016 (GLOBE NEWSWIRE) -- At the end of the settlement date of December 31, 2015, short interest in 2,304 Nasdaq Global MarketSM securities totaled 7,935,162,458 shares compared with 8,094,051,950...
CTG to Present at NobleCon12 on January 19
Jan 12, 2016 21:05 pm UTC| Business
BUFFALO, N.Y., Jan. 12, 2016 (GLOBE NEWSWIRE) -- CTG (NASDAQ:CTG), an information technology (IT) solutions and services company, today announced that Cliff Bleustein, President and CEO, and Brendan Harrington, CFO, will...
Cempra Completes Public Offering of Common Stock
Jan 12, 2016 21:05 pm UTC| Business
CHAPEL HILL, N.C., Jan. 12, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial...
CareDx and Diaxonhit Announce Completion of Technology Transfer of AlloMap® Test in Europe
Jan 12, 2016 21:05 pm UTC| Business
BRISBANE, Calif. and PARIS, Jan. 12, 2016 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated,...
Jan 12, 2016 21:02 pm UTC| Business
NEW YORK, Jan. 12, 2016 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi Korsinsky, LLP: To: All persons or entities who purchased New Source Energy Partners L.P. 11% Series A Cumulative Convertible...
CSX Corporation Announces Fourth-Quarter and Full-Year Earnings Results
Jan 12, 2016 21:02 pm UTC| Business
Highlights: Solid fourth quarter and full-year financial performance, including the company’s first sub-70 full-year operating ratio, despite challenging market conditionsContinued focus on pricing, efficiency and...